Hims & Hers Health logo
Hims & Hers Health HIMS
$ 15.91 0.57%

Annual report 2025
added 02-23-2026

report update icon

Hims & Hers Health Financial Statements 2011-2026 | HIMS

Annual Financial Statements Hims & Hers Health

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

3.51 B 11 B 2.13 B 2 B 975 M 515 M - - - - - - - - -

Shares

225 M 216 M 209 M 205 M 187 M 35.4 M - - - - - - - - -

Historical Prices

15.6 50.9 10.2 9.79 5.22 14.6 10 - - - - - - - -

Net Income

128 M 126 M -23.5 M -65.7 M -108 M -18.1 M - - - - - - - - -

Revenue

2.35 B 1.48 B 872 M 527 M 272 M 149 M - - - - - - - - -

Cost of Revenue

614 M 303 M 157 M 118 M 67.4 M 39.3 M 38 M - - - - - - - -

Gross Profit

1.73 B 1.17 B 715 M 409 M 204 M 109 M - - - - - - - - -

Operating Income

106 M 61.9 M -29.5 M -68.7 M -115 M -15.1 M -74.4 M - - - - - - - -

Interest Expense

23.1 M 9.81 M 8.96 M 2.92 M 445 K 258 K 369 K - - - - - - - -

EBITDA

160 M 79 M -19.9 M -61.2 M -111 M -14.1 M - - - - - - - - -

Operating Expenses

1.63 B 1.11 B 744 M 477 M 320 M 125 M - - - - - - - - -

General and Administrative Expenses

273 M 168 M 130 M 98.2 M 114 M 26 M - - - - - - - - -

All numbers in USD currency

Quarterly Income Statement Hims & Hers Health

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

226 M 224 M 222 M 217 M 215 M 213 M 210 M 208 M 207 M - 205 M 204 M 203 M - 200 M 192 M 153 M - 35.6 M 35.3 M 34.6 M - - 5.03 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

15.8 M 42.5 M 49.5 M 75.6 M 13.3 M 11.1 M -7.57 M -7.16 M -10.1 M - -18.8 M -19.7 M -16.3 M - -15.9 M -9.15 M -51.4 M - -5.87 M -981 K -6.03 M - 436 K -16.6 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

599 M 545 M 586 M 402 M 316 M 278 M 227 M 208 M 191 M - 145 M 114 M 101 M - 74.2 M 60.7 M 52.3 M - 41.3 M 35.9 M 30.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

157 M 129 M 155 M 83.7 M 59 M 49.1 M 39.4 M 37.8 M 37.3 M - 30.4 M 26.4 M 26.6 M - 19.3 M 13.4 M 12.1 M - 10 M 10.2 M 9.44 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

442 M 416 M 431 M 318 M 257 M 229 M 187 M 170 M 153 M - 114 M 87.2 M 74.8 M - 54.9 M 47.3 M 40.2 M - 31.3 M 25.7 M 20.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

11.8 M 26.7 M 57.9 M 22.4 M 11 M 9.9 M -8.55 M -9.24 M -11.3 M - -20 M -20.2 M -16.9 M - -27.7 M -17.4 M -48.4 M - -3.32 M -979 K -6.22 M - -450 K -16.6 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

8.04 M - - 1.22 M 2.39 M 2.5 M 2.23 M 2.24 M 1.88 M - 677 K 402 K 320 K - 219 K 325 K - - - - 10 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

21 M 29.5 M 66.2 M 23.3 M 11.8 M 12.9 M -7.75 M -8.24 M -9.15 M - -19 M -19.1 M -15.2 M - -25.2 M -16.5 M -48 M - -2.63 M -587 K -6.04 M - -450 K -16.6 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

430 M 389 M 373 M 296 M 246 M 219 M 196 M 179 M 165 M - 134 M 107 M 91.7 M - 82.5 M 64.7 M 88.7 M - 34.6 M 26.6 M 26.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

80.7 M 67.3 M 48.6 M 44.6 M 40.6 M 34.6 M 35.9 M 31.1 M 30.5 M - 26.2 M 22.6 M 21.8 M - 25.2 M 36.7 M 61.7 M - 2.34 M 124 K 247 K - 450 K 16.6 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Hims & Hers Health HIMS
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Hims & Hers Health plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Household products industry

Issuer Price % 24h Market Cap Country
Natura &Co Holding S.A. Natura &Co Holding S.A.
NTCO
- - $ 9.02 B -
The Clorox Company The Clorox Company
CLX
$ 118.97 -1.8 % $ 14.7 B usaUSA
Colgate-Palmolive Company Colgate-Palmolive Company
CL
$ 95.21 -0.3 % $ 77 B usaUSA
The Estée Lauder Companies The Estée Lauder Companies
EL
$ 99.28 0.57 % $ 35.8 B usaUSA
Coty Coty
COTY
$ 2.43 -1.02 % $ 2.12 B usaUSA
Dogness (International) Corporation Dogness (International) Corporation
DOGZ
$ 1.5 2.04 % $ 50.6 M chinaChina
Acme United Corporation Acme United Corporation
ACU
$ 44.08 -0.61 % $ 163 M usaUSA
Helen of Troy Limited Helen of Troy Limited
HELE
$ 16.7 -1.36 % $ 384 M bermudaBermuda
e.l.f. Beauty e.l.f. Beauty
ELF
$ 81.0 -0.07 % $ 4.43 B usaUSA
Revlon Revlon
REV
- -4.41 % $ 212 M usaUSA
Church & Dwight Co. Church & Dwight Co.
CHD
$ 102.33 -0.66 % $ 24.8 B usaUSA
Inter Parfums Inter Parfums
IPAR
$ 93.64 -1.95 % $ 3 B usaUSA
Kimberly-Clark Corporation Kimberly-Clark Corporation
KMB
$ 103.94 -0.67 % $ 34.5 B usaUSA
LifeVantage Corporation LifeVantage Corporation
LFVN
$ 4.83 0.57 % $ 59.2 M usaUSA
Mannatech, Incorporated Mannatech, Incorporated
MTEX
$ 6.73 - $ 12.6 M usaUSA
Nu Skin Enterprises Nu Skin Enterprises
NUS
$ 7.48 -0.93 % $ 369 M usaUSA
Newell Brands Newell Brands
NWL
$ 4.42 1.14 % $ 1.85 B usaUSA
Edgewell Personal Care Company Edgewell Personal Care Company
EPC
$ 21.22 -0.89 % $ 1.05 B usaUSA
United-Guardian United-Guardian
UG
$ 6.59 - $ 30.3 M usaUSA
Unilever PLC Unilever PLC
UL
$ 68.76 -0.56 % $ 132 B britainBritain
Nature's Sunshine Products Nature's Sunshine Products
NATR
$ 27.11 0.48 % $ 517 M usaUSA
The Procter & Gamble Company The Procter & Gamble Company
PG
$ 158.2 -0.98 % $ 372 B usaUSA
Spectrum Brands Holdings Spectrum Brands Holdings
SPB
$ 78.03 0.25 % $ 2.01 B usaUSA
USANA Health Sciences USANA Health Sciences
USNA
$ 19.0 -2.31 % $ 366 M usaUSA